James P Flynn
CIK 1955965 · last filed 2025-12-22
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$84.5K
Companies
4
Total Filings
12
Lifetime Open-Market Net
$120.5K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LITS | Director | 100,000 | $0.74 | $74.1K | $120.5K | 4 | 2025-12-22 |
| Lite Strategy, Inc. (MEIP) Delisted | Director | 7,900 | $3.20 | $25.3K | $0 | 4 | 2025-07-17 |
| SYBX | Director | 15,000 | $0.69 | $10.3K | $0 | 2 | 2025-04-29 |
| Oruka Therapeutics, Inc. (ABIO) Delisted | Director | — | $28.80 | — | $0 | 2 | 2024-01-31 |
Recent Filings · Page 2 of 2
12 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-12-20 | Lite Strategy, Inc. (MEIP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-12-19 | Oruka Therapeutics, Inc. (ABIO) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–12 of 12
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.